Massachusetts Financial Services’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.2M | Buy |
1,365,932
+53,277
| +4% | +$2.26M | 0.02% | 490 |
|
|
2025
Q4 | $60.8M | Buy |
1,312,655
+518,721
| +65% | +$21.7M | 0.02% | 445 |
|
|
2025
Q3 | $27.8M | Sell |
793,934
-5,252
| -0.7% | -$183K | 0.01% | 581 |
|
|
2025
Q2 | $23.6M | Buy |
799,186
+85,332
| +12% | +$2.43M | 0.01% | 591 |
|
|
2025
Q1 | $21.3M | Buy |
713,854
+109,655
| +18% | +$3.35M | 0.01% | 593 |
|
|
2024
Q4 | $17.3M | Sell |
604,199
-161,493
| -21% | -$5.34M | 0.01% | 617 |
|
|
2024
Q3 | $29.6M | Buy |
765,692
+116,327
| +18% | +$4.15M | 0.01% | 541 |
|
|
2024
Q2 | $20.9M | Sell |
649,365
-12,433
| -2% | -$431K | 0.01% | 575 |
|
|
2024
Q1 | $25.7M | Sell |
661,798
-3,320
| -0.5% | -$116K | 0.01% | 550 |
|
|
2023
Q4 | $20.5M | Buy |
665,118
+599
| +0.1% | +$15K | 0.01% | 571 |
|
|
2023
Q3 | $14.9M | Buy |
664,519
+1,136
| +0.2% | +$25.9K | 0.01% | 600 |
|
|
2023
Q2 | $14.3M | Sell |
663,383
-6,104
| -0.9% | -$139K | ﹤0.01% | 584 |
|
|
2023
Q1 | $16.1M | Sell |
669,487
-150,125
| -18% | -$3.98M | 0.01% | 575 |
|
|
2022
Q4 | $19M | Buy |
819,612
+2,686
| +0.3% | +$54.2K | 0.01% | 555 |
|
|
2022
Q3 | $13.1M | Sell |
816,926
-53,380
| -6% | -$941K | ﹤0.01% | 594 |
|
|
2022
Q2 | $15.4M | Buy |
870,306
+5,524
| +0.6% | +$92.9K | 0.01% | 578 |
|
|
2022
Q1 | $17.6M | Buy |
864,782
+22,401
| +3% | +$423K | 0.01% | 597 |
|
|
2021
Q4 | $15.7M | Buy |
842,381
+20,634
| +3% | +$402K | ﹤0.01% | 626 |
|
|
2021
Q3 | $16.2M | Sell |
821,747
-10,807
| -1% | -$234K | ﹤0.01% | 631 |
|
|
2021
Q2 | $19.7M | Buy |
832,554
+189,232
| +29% | +$4.37M | 0.01% | 617 |
|
|
2021
Q1 | $15.2M | Sell |
643,322
-16,417
| -2% | -$390K | ﹤0.01% | 633 |
|
|
2020
Q4 | $13.2M | Buy |
659,739
+9,940
| +2% | +$194K | ﹤0.01% | 626 |
|
|
2020
Q3 | $13.5M | Sell |
649,799
-17,119
| -3% | -$309K | ﹤0.01% | 606 |
|
|
2020
Q2 | $11.7M | Buy |
666,918
+183,352
| +38% | +$3.59M | ﹤0.01% | 593 |
|
|
2020
Q1 | $7.9M | Sell |
483,566
-10,572
| -2% | -$218K | ﹤0.01% | 607 |
|
|
2019
Q4 | $10.2M | Sell |
494,138
-94,007
| -16% | -$1.57M | ﹤0.01% | 602 |
|
|
2019
Q3 | $6.75M | Sell |
588,145
-2,247
| -0.4% | -$25.7K | ﹤0.01% | 637 |
|
|
2019
Q2 | $7.76M | Buy |
590,392
+3,450
| +0.6% | +$46.1K | ﹤0.01% | 643 |
|
|
2019
Q1 | $8.89M | Sell |
586,942
-76,556
| -12% | -$1.23M | ﹤0.01% | 626 |
|
|
2018
Q4 | $11.4M | Buy |
663,498
+13,874
| +2% | +$237K | 0.01% | 578 |
|
|
2018
Q3 | $9.57M | Buy |
649,624
+229,968
| +55% | +$4.08M | ﹤0.01% | 633 |
|
|
2018
Q2 | $10M | Buy |
419,656
+5,818
| +1% | +$143K | ﹤0.01% | 626 |
|
|
2018
Q1 | $10.6M | Sell |
413,838
-35,427
| -8% | -$844K | ﹤0.01% | 603 |
|
|
2017
Q4 | $8.29M | Sell |
449,265
-223,362
| -33% | -$3.2M | ﹤0.01% | 638 |
|
|
2017
Q3 | $7.06M | Buy |
672,627
+4,069
| +0.6% | +$44.9K | ﹤0.01% | 638 |
|
|
2017
Q2 | $8.36M | Buy |
668,558
+28,369
| +4% | +$280K | ﹤0.01% | 628 |
|
|
2017
Q1 | $6.44M | Buy |
640,189
+191,062
| +43% | +$2.84M | ﹤0.01% | 632 |
|
|
2016
Q4 | $6.99M | Sell |
449,127
-59,868
| -12% | -$995K | ﹤0.01% | 635 |
|
|
2016
Q3 | $9.8M | Buy |
508,995
+8,686
| +2% | +$103K | ﹤0.01% | 576 |
|
|
2016
Q2 | $5.93M | Buy |
500,309
+138,305
| +38% | +$2.28M | ﹤0.01% | 629 |
|
|
2016
Q1 | $6.57M | Buy |
362,004
+4,420
| +1% | +$80.3K | ﹤0.01% | 615 |
|
|
2015
Q4 | $9.83M | Sell |
357,584
-2,382
| -0.7% | -$50.2K | 0.01% | 591 |
|
|
2015
Q3 | $7.96M | Sell |
359,966
-128,544
| -26% | -$2.32M | ﹤0.01% | 623 |
|
|
2015
Q2 | $8.72M | Buy |
+488,510
| New | +$8.45M | ﹤0.01% | 624 |
|
Other funds holding COLL
EAM
VCM
RCMNY